Graph Therapeutics vs Infinimmune
Graph Therapeutics vs Infinimmune, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Graph Therapeutics is on 44/100 and Infinimmune on 60/100.
Where each one leads
Graph Therapeutics
- domain rating: 27/100 against 20/100
Infinimmune
- our overall score: 60/100 against 44/100
- funding raised: $75.0M against $5.0M
- LinkedIn following: 4,055 against 2,302
At a glance
| Measure | Graph Therapeutics | Infinimmune |
|---|---|---|
| What it is | Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis. | Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms. |
| Category | Biotechnology, Artificial Intelligence, Healthcare, Drug Discovery | Biotechnology, Pharmaceuticals, Artificial Intelligence, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2021 | 2017 |
| Headquarters | Boston, Austria | Alameda, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Graph Therapeutics | Infinimmune |
|---|---|---|
| Employees | Not published | 22 |
| Total funding | $5.0M | $75.0M |
| Latest round | Funding Round | Series A |
| LinkedIn followers | 2,302 | 4,055 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Graph Therapeutics | Infinimmune |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 44/100 | 60/100 |
| Traction | 33/100 | 53/100 |
| Team | Not published | 70/100 |
| Search visibility | 42/100 | 23/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (41/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 27/100 | 20/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Graph Therapeutics | Infinimmune |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Framer | Webflow |
| Analytics | Not detected | Google Analytics 4 |
Graph Therapeutics vs Infinimmune: common questions
Which is better, Graph Therapeutics or Infinimmune?
On our 0-100 score Infinimmune rates higher (60/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Graph Therapeutics and Infinimmune compare on the numbers?
Graph Therapeutics leads on domain rating (27/100 against 20/100). Infinimmune leads on our overall score (60/100 against 44/100), funding raised ($75.0M against $5.0M), LinkedIn following (4,055 against 2,302).
Read the full Graph Therapeutics review and pricing or the Infinimmune review and pricing. You can also browse other Graph Therapeutics alternatives we track.